Turtle Cameron Insider Trades

Insider Trading History

Track insider trading activity for Turtle Cameron. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $58.1M 587,364 shares
Last Trade
Jul 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.32M 15,000 shares
$87.69
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $60.3M 608,983 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.06M 15,000 shares
$70.44
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $61.6M 622,240 shares
Last Trade
May 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.07M 15,000 shares
$71.36
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $62.4M 630,196 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$740k 15,000 shares
$49.33
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $64.5M 651,640 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$633k 15,000 shares
$42.19
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $66.5M 671,583 shares
Last Trade
Feb 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$492k 15,000 shares
$32.80
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $52.2M 528,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.2M 528,000 shares
$30.61
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $66.7M 674,198 shares
Last Trade
Jan 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$460k 15,000 shares
$30.67
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $68.4M 690,912 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$435k 15,000 shares
$29.02
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $71.1M 718,752 shares
Last Trade
Nov 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.05M 45,000 shares
$23.33
$98.95
Oruka Therapeutics
Oruka Therapeutics ORKA
Director
Holding Value $1.53M 17,500 shares
Last Trade
Jun 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$206k 17,500 shares
$11.77
$87.47
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $36.6M 370,000 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.01M 370,000 shares
$21.66
$98.95
Oruka Therapeutics
Oruka Therapeutics ORKA
Director
Holding Value $0 0 shares
Last Trade
Aug 29, 2024 Sale
No data
No data
$87.47
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $73.9M 746,907 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.02k 400 shares
$22.56
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $27.5M 277,750 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.18M 277,750 shares
$25.86
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $73.9M 746,507 shares
Last Trade
Nov 24, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$98.95
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$98.95
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2023 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$200k 18,086 shares
$11.04
$12.01
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Chief Executive Officer
Holding Value $8.97M 746,507 shares
Last Trade
Nov 24, 2023 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$7.99M 723,440 shares
$11.04
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Chief Executive Officer
Holding Value $37M 374,000 shares
Last Trade
Nov 22, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$98.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up